Discordance between commercial genotyping platforms for APOE polymorphisms in Libyan patients with coronary heart disease: a methodological pilot study

Commercial APOE genotyping platforms are widely used in cardiovascular genetic studies, but their performance in genetically understudied populations is rarely verified. This pilot study compared a reverse-hybridization strip assay and a real-time PCR (qPCR) kit for APOE genotyping (rs429358 and rs7412) in Libyan participants and examined how their calls disagreed. In a validation subset of 28 individuals, the strip assay gave no valid result in 5 (17.9%). Among the 23 samples valid on both platforms, genotype concordance was 8/23 (34.8%; 95% CI 18.8–55.1%) and Cohen’s κ was 0.19 (slight agreement). Single-SNP agreement was 65.2% for rs429358 and 60.9% for rs7412. The strip assay consistently reported more minor alleles than qPCR, but without a sequencing reference standard it is unknown which platform is correct. APOE genotype frequencies in Libyan patients with coronary heart disease could therefore not be reliably determined; strip-derived calls for 60 patients are provided only as unverified, exploratory data (Additional file 1). Sequencing confirmation should precede any larger APOE association study in this population.

Authors

Institutions

Publication Details

Journal
BMC Research Notes
Published
2026-11-18
DOI
https://doi.org/10.1186/s13104-026-08134-5
Primary Topic
Genetic Associations and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Discordance between commercial genotyping platforms for APOE polymorphisms in Libyan patients with coronary heart disease: a methodological pilot study

Mohamed Nouri El-Attug, Emhamed A Boras, Salem Hasn Abukres, Samya M Khaled et al.
BMC Research Notes
Genetic Associations and Epidemiology
article

Discordance between commercial genotyping platforms for APOE polymorphisms in Libyan patients with coronary heart disease: a methodological pilot study

Mohamed Nouri El-Attug, Emhamed A Boras, Salem Hasn Abukres, Samya M Khaled, Abdulrazag F. Ahmed, Khaled H. Alzrigan
article en

Abstract

Commercial APOE genotyping platforms are widely used in cardiovascular genetic studies, but their performance in genetically understudied populations is rarely verified. This pilot study compared a reverse-hybridization strip assay and a real-time PCR (qPCR) kit for APOE genotyping (rs429358 and rs7412) in Libyan participants and examined how their calls disagreed. In a validation subset of 28 individuals, the strip assay gave no valid result in 5 (17.9%). Among the 23 samples valid on both platforms, genotype concordance was 8/23 (34.8%; 95% CI 18.8–55.1%) and Cohen’s κ was 0.19 (slight agreement). Single-SNP agreement was 65.2% for rs429358 and 60.9% for rs7412. The strip assay consistently reported more minor alleles than qPCR, but without a sequencing reference standard it is unknown which platform is correct. APOE genotype frequencies in Libyan patients with coronary heart disease could therefore not be reliably determined; strip-derived calls for 60 patients are provided only as unverified, exploratory data (Additional file 1). Sequencing confirmation should precede any larger APOE association study in this population.

BMC Research Notes
University of Tripoli (LY), Alasmarya Islamic University (LY), University Elmergib (LY), Libyan Academy (LY)
Good health and well-being
Genetic Associations and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon